PubRank

Janet M Raboud

Author PubWeight™ 34.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 2009 2.77
2 Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study. PLoS One 2009 1.87
3 Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003 1.76
4 Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007 1.55
5 Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients. AIDS 2007 1.47
6 No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults. AIDS 2011 1.22
7 Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis. PLoS Med 2010 1.19
8 Association of vitamin D related information from a telephone interview with 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev 2008 0.99
9 Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada. HIV Clin Trials 2011 0.96
10 Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada. PLoS One 2012 0.96
11 The effect of an education program on violence in the emergency department. Ann Emerg Med 2002 0.95
12 Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. Am J Epidemiol 2008 0.93
13 Vitamin D association with estradiol and progesterone in young women. Cancer Causes Control 2010 0.93
14 Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens. Antivir Ther 2004 0.92
15 Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Antivir Ther 2014 0.92
16 Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. AIDS 2014 0.83
17 Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study. BMJ Open 2014 0.82
18 Light and exercise and melatonin production in women. Am J Epidemiol 2005 0.81
19 Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV. AIDS Res Hum Retroviruses 2014 0.80
20 Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-). J Int Assoc Physicians AIDS Care (Chic) 2012 0.80
21 Impact of CMV therapy with valganciclovir on immune activation and the HIV viral load in semen and blood: an observational clinical study. J Acquir Immune Defic Syndr 2014 0.80
22 The importance of motherhood in HIV-positive women of reproductive age in Ontario, Canada. AIDS Care 2013 0.79
23 Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial. Trials 2010 0.79
24 Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort. AIDS 2013 0.79
25 Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. J Int Assoc Provid AIDS Care 2013 0.79
26 Impact of a mandatory infection control education program on nosocomial acquisition of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2009 0.78
27 Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada. J Int Assoc Provid AIDS Care 2013 0.78
28 Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy. AIDS Res Hum Retroviruses 2012 0.77
29 Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection. Clin Infect Dis 2013 0.77
30 Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada. ISRN Obstet Gynecol 2012 0.76
31 Time-dependent bias in hepatitis C classification. Epidemiology 2015 0.76
32 Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy. AIDS Care 2009 0.76
33 Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophy. HIV Clin Trials 2011 0.76
34 A study of provider-caregiver communication in paediatric ambulatory care. Paediatr Child Health 2006 0.75
35 Implications of the age range in a population-based BRCA1 testing program with eligibility based on family history of breast and ovarian cancer. Genet Test 2004 0.75
36 Gastrointestinal Symptom Distress is Associated With Worse Mental and Physical Health-Related Quality of Life. J Acquir Immune Defic Syndr 2017 0.75